Issue Brief
Consumer Survey - Disclosure of Industry Payments to Physicians
Jun 16, 2008
Americans want to know about physician ties to pharmaceutical companies. More info
Issue Brief
| Summary | Type |
|---|---|
| Video | |
PharmFree ScorecardMost of the 150 U.S. medical schools are failing when it comes to building strong conflict of interest policies to limit pharmaceutical marketing on campus, according to the American Medical Student Association (AMSA) PharmFree Scorecard released today. More info |
Report |
Disclosure of Industry Payments to PhysiciansThis Prescription Project survey shows Americans are eager to understand financial ties between physicians and pharmaceutical industry. More info |
Report |
Time For ChangeAcademic medical centers (AMCs) form the intellectual core of medicine, training future doctors and researchers, and establishing standards that guide practicing physicians in the wider community. Where pharmaceutical industry marketing conflicts with the goals of patient care and professionalism, AMCs can provide leadership and guidance by establishing new standards on physician-industry relationships. More info |
Report |
Advancing Integrity in Medical EducationThe Pew Charitable Trusts is working to decrease the influence of pharmaceutical marketing on doctors’ practices. With a three-year grant from the Attorney General Consumer and Prescriber Education Grant Program, Pew is collaborating several partners to improve conflict-of-interest policies within the 158 medical schools and 400 major teaching hospitals in the United States. More info |
Other Resource |
One Step Closer to Medical Transparency: Pew's Analysis of the Final Rule for the Physician Payments Sunshine ActOn Feb. 1, 2013, the Centers for Medicare & Medicaid Services published the final rule guiding implementation of the Physician Payments Sunshine Act, which Congress passed as part of the Affordable Care Act in March 2010 to increase transparency in the relationships between physicians and drug and medical device makers. Here are some of the highlights. More info |
Other Resource |
Persuading the Prescribers: Pharmaceutical Industry Marketing and its Influence on Physicians and PatientsIn 2011, the pharmaceutical industry spent nearly $29 billion on drug promotion — more than $25 billion on marketing directly to physicians and almost $4 billion on advertising directly to consumers (mainly through television commercials). This multi-pronged approach is designed to promote its products by influencing doctors’ prescribing practices. More info |
Other Resource |
Letter from Pew to CMS Regarding Physician Payments Sunshine ActPrescription project director Danny Carlat identifies issues with the Physician Payments Sunshine Act requiring further clarification and guidance. Addressing those would ensure that manufacturers can appropriately implement the final rule, and enable consumers to benefit from transparency reports published by the Centers for Medicare & Medicaid Services. More info |
Issue Brief |
Pew Comments on Centers for Medicaid and Medicare Services' Information Collection Activities Draft GuidanceThe Pew Charitable Trusts appreciates this opportunity to submit comments to CMS's "Information Collection Activities" draft guidance. We suggest that both the research and non-research payment templates be modified in order to make it easier for consumers to identify which drugs, devices, biologicals, or medical supplies are associated with particular transfers of value. More info |
Issue Brief |
Written Statement of Record Regarding the Sunshine Act by Dr. Daniel J. Carlat of the Pew Health GroupDr. Daniel Carlat, Director of the Pew Prescription Project, appeared before the U.S. Senate Special Committee on Aging to testify about the importance of implementing the Physician Payments Sunshine Act as quickly as possible. More info |
Issue Brief |
Joint Comments with Medtronic to CMS on Sunshine ImplementationThe Pew Charitable Trusts “Pew” and Medtronic, Inc. are pleased to jointly comment on the Department of Health and Human Services, Centers for Medicare & Medicaid Services proposed rule implementing Section 6002 of the Affordable Care Act. More info |
Issue Brief |
Comments to CMS on Sunshine ImplementationPew’s main goals in commenting on the proposed rule are to ensure timely implementation and to promote the interest of full transparency by ensuring that data is collected, reported, and published in the most complete, consistent and accurate manner possible. More info |
Issue Brief |
Pew Health Group comments on the implementation of Section 6002 of the Patient Protection and Affordable Care Act"The Pew Health Group of The Pew Charitable Trusts welcomes the opportunity to submit comments regarding the Centers for Medicare & Medicaid Services' ("CMS") proposed rule for Medicare, Medicaid, Children's Health Insurance Programs; Transparency Reports and Reporting of Physician Ownership or Interests." More info |
Issue Brief |
Joint Letter to HHS on Sunshine ImplementationDear Secretary Sebelius: We are writing to urge you to fully implement Section 1128G of the Social Security Act, the Physician Payments Sunshine Provision, which was added as Section 6002 of the Patient Protection and Affordable Care Act (PPACA). More info |
Issue Brief |
Federal Reporting Requirements on Payments to Physicians: Impact on State LawsWith the enactment of the Patient Protection and Affordable Care Act in March 2010, all U.S. manufacturers of drugs, devices, biologics or medical supplies covered under government-funded insurance programs are now required to report certain information to HHS. This fact sheet describes how these federal reporting requirements affect comparable state disclosure laws. More info |
Issue Brief |
Allan Coukell
Daniel Carlat
